ATE312611T1 - Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen - Google Patents

Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen

Info

Publication number
ATE312611T1
ATE312611T1 AT98921544T AT98921544T ATE312611T1 AT E312611 T1 ATE312611 T1 AT E312611T1 AT 98921544 T AT98921544 T AT 98921544T AT 98921544 T AT98921544 T AT 98921544T AT E312611 T1 ATE312611 T1 AT E312611T1
Authority
AT
Austria
Prior art keywords
pct
mizolastine
inflammation
treatment
production
Prior art date
Application number
AT98921544T
Other languages
English (en)
Inventor
Itzchak Angel
Sonia Arbilla
Luc Even
Jon Goldhill
Philippe Pichat
Nigel Roome
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE312611T1 publication Critical patent/ATE312611T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT98921544T 1997-04-17 1998-04-16 Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen ATE312611T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704801A FR2762214B1 (fr) 1997-04-17 1997-04-17 Utilisation de la mizolastine pour la preparation d'un medicament destine au traitement de l'inflammation
PCT/FR1998/000765 WO1998047511A1 (fr) 1997-04-17 1998-04-16 Utilisation de la mizolastine pour la preparation d'un medicament destine au traitement de l'inflammation

Publications (1)

Publication Number Publication Date
ATE312611T1 true ATE312611T1 (de) 2005-12-15

Family

ID=9506075

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921544T ATE312611T1 (de) 1997-04-17 1998-04-16 Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen

Country Status (11)

Country Link
US (1) US6140335A (de)
EP (1) EP1007047B1 (de)
JP (2) JP2001523242A (de)
AT (1) ATE312611T1 (de)
AU (1) AU7436098A (de)
DE (1) DE69832796T2 (de)
DK (1) DK1007047T3 (de)
ES (1) ES2253816T3 (de)
FR (1) FR2762214B1 (de)
WO (1) WO1998047511A1 (de)
ZA (1) ZA983211B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0958820A1 (de) * 1998-05-19 1999-11-24 Sanofi-Synthelabo Verwendung von einem Imidazolderivat zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunerkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP2001523242A (ja) 2001-11-20
FR2762214B1 (fr) 2000-10-06
ES2253816T3 (es) 2006-06-01
EP1007047B1 (de) 2005-12-14
US6140335A (en) 2000-10-31
DE69832796T2 (de) 2006-08-31
JP5271188B2 (ja) 2013-08-21
DE69832796D1 (de) 2006-01-19
FR2762214A1 (fr) 1998-10-23
EP1007047A1 (de) 2000-06-14
WO1998047511A1 (fr) 1998-10-29
JP2009292827A (ja) 2009-12-17
DK1007047T3 (da) 2006-05-08
ZA983211B (en) 1998-10-22
AU7436098A (en) 1998-11-13

Similar Documents

Publication Publication Date Title
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
DE69507029T2 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DE69513167D1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
ATE249828T1 (de) Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen
ATE219670T1 (de) Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia
DE59508961D1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
ATE252897T1 (de) Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen
BG105275A (en) Tan-1057 derivatives
DE69329687D1 (de) Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
ATE312611T1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
NO990450L (no) Behandling av sinnslidelser
DE50103012D1 (de) Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen
ATE189385T1 (de) Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems
ATE186640T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen
ATE215368T1 (de) Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht
DE69328205T2 (de) Rektale Flunisolid-Zubereitung zur Behandlung entzündlicher Darmerkrankungen
ATE221068T1 (de) Anellierte beta-carboline

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007047

Country of ref document: EP